Recruiting Chronic Myeloid Leukemia Studies in Capital Federal
About Chronic Myeloid Leukemia Clinical Trials in Capital Federal
Chronic myeloid leukemia (CML) is a type of cancer that starts in blood-forming cells of the bone marrow, characterized by the Philadelphia chromosome and BCR-ABL fusion gene. It was one of the first cancers treated successfully with targeted therapy. Tyrosine kinase inhibitors like imatinib have transformed CML into a manageable chronic condition.
There are currently 1 chronic myeloid leukemia clinical trials recruiting participants in Capital Federal, . These studies are seeking a combined 347 participants. Research is being sponsored by Novartis Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Chronic Myeloid Leukemia Clinical Trials in Capital Federal — FAQ
Are there chronic myeloid leukemia clinical trials in Capital Federal?
Yes, there are 1 chronic myeloid leukemia clinical trials currently recruiting in Capital Federal, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Capital Federal?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Capital Federal research site will contact you about next steps.
Are clinical trials in Capital Federal free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Capital Federal studies also compensate for your time and travel.
What chronic myeloid leukemia treatments are being tested?
The 1 active trials in Capital Federal are testing new therapies including novel drugs, biologics, and treatment approaches for chronic myeloid leukemia.
Data updated March 2, 2026 from ClinicalTrials.gov